Rheumatology
Conference Coverage
COVID-19 vaccine won’t be a slam dunk
A key safety concern to watch for in the coming months is whether a vaccine candidate is able to sidestep the issue of antibody-dependent...
Conference Coverage
TNF inhibitors may dampen COVID-19 severity
New findings from the COVID-19 Global Rheumatology Alliance Registry.
News
ACR gives guidance on rheumatic disease management during pandemic
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be...
News
Case series suggests biologics, JAK inhibitors safe during pandemic
Investigators saw no increase in hospitalizations versus the general population in New York City.
News
COVID-19: Frequently asked clinical questions
Should I continue to vaccinate my pediatric population during peak COVID-19?
News
Infusion center directors shuffle treatment services in the era of COVID-19
“We look for ways to try to reassure patients and to comfort them, and work with them to make the best of the situation,” Dr. Christopher R....
News
Rheumatologists seek to reassure amid hydroxychloroquine shortage
Rheumatologists Jill P. Buyon and Peter M. Izmirly answer questions about the availability of hydroxychloroquine during the COVID-19 pandemic, and...
News
Stronger links forged between RA and asthma, COPD
Findings from the first-ever prospective study to evaluate asthma and COPD as risk factors for RA suggest providers should lower bar for...
News
Rheumatologists to share knowledge in COVID-19 patient-centered registry
The soon-to-be launched registry will help guide clinicians in the treatment of patients with rheumatologic disorders treated with...
News
Inactivated flu vaccine succeeds among autoimmune rheumatic disease patients
Safety and effectiveness data support use of inactivated flu vaccine for individuals with autoimmune rheumatic diseases.